Search results
Analysis | Federal officials urge mpox vaccinations to blunt a summer surge
Washington Post· 5 days agoToday’s edition: A growing trend of at-home medical testing is booming, but medical providers worry...
BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class...
Morningstar· 5 days ago(NASDAQ: BIIB)? Did you lose money in your investment in Biogen Inc.? Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased ...
With A Similar Revenue Base, Is Johnson & Johnson A Better Pick Despite The 30% Fall In Tesla Stock...
Forbes· 4 days agoIn this case, although these companies are from different sectors, they share a similar revenue base...
FDA accepts filing of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of...
Benzinga· 6 days agoBioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that that the U.S. Food and Drug Administration (FDA) has accepted Eisai's Supplemental Biologics ...
FDA accepts filing of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of...
KSAN - KLST San Angelo· 6 days agoBioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that that the U.S. Food and Drug Administration (FDA) has accepted Eisai's Supplemental Biologics ...